Renji Hospital

This study is testing whether a smartwatch that uses artificial intelligence (AI) can help people recover better after a heart attack. 200 patients will wear a smartwatch for 3 months after leaving the hospital. The goal is to see if the AI's analysis of the watch's data can help…

This study is testing a new treatment for high-risk bladder cancer that has not spread into the muscle wall. Doctors will put a specially engineered virus directly into the bladder to try to kill cancer cells. The study will enroll about 18 patients to find a safe dose and see if…

This study is testing whether adding a new immunotherapy drug (serplulimab) to standard chemotherapy before surgery helps shrink tumors more effectively in people with triple-negative breast cancer. It will involve about 46 women with early-stage disease to see if this combinatio…

This study aims to find the best timing for treating all blocked heart arteries in patients who have just had a certain type of heart attack. It will compare doing all the artery-clearing procedures at once versus doing them in stages over several weeks. The goal is to see which …

This study is testing a new two-drug combination for people with advanced kidney cancer that has spread or cannot be removed by surgery, and whose cancer has gotten worse after previous immunotherapy. The trial will see if adding a new drug called JS004 to an existing immunothera…

This study is testing whether adding two new immunotherapy drugs, called iparomlimab and tuvonralimab (together as QL1706), to standard chemotherapy before surgery can help shrink tumors in people with a common type of breast cancer. The goal is to see if this combination leads t…

This study is testing a device called a flow diverter, which is a tiny mesh tube placed in a brain artery. It aims to safely block off dangerous, non-round brain aneurysms by redirecting blood flow away from them. The trial will enroll 168 adults to see how well the device works …